Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2015 Oct 3;289(2):155–162. doi: 10.1016/j.taap.2015.09.029

Figure 2. Prodan is displaced from drug site I by MG modification of HSA.

Figure 2

Prodan bound to HSA (prodan-HSA complex, 75 μM) was treated with a dilution of MG and the fluorescence (excitation 380 nm, emission 465 nm, filter cut-off 420 nm) was measured after 30 minutes. Means ± SD for three separate experiments are given. Significant (*p<0.05; ** p<0.01; *** p<0.001) as compared to control (HSA without MG treatment)